Nuclear Radiology: Page 26

EMA publishes new guidance on radiopharmaceuticals

By AuntMinnieEurope.com staff writers

The European Medicines Agency (EMA) has published a draft guideline for nonclinical safety testing for radiopharmaceuticals, the European Association of Nuclear Medicine has announced.

May 2, 2019

New breast CAD advances detection with MRI, PET

By Wayne Forrest

Researchers from Austria have developed a new computer-aided segmentation and diagnostic (CAD) algorithm to distinguish between cancerous and benign breast lesions using PET and MRI data. Their study was published online on 27 April in European Radiology Experimental.

May 2, 2019

ANSTO secures molecular imaging partnership

By AuntMinnieEurope.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) has signed a strategic partnership with the University of Sydney.

April 23, 2019

Blue Earth's Axumin agent added to EAU guidelines

By AuntMinnieEurope.com staff writers

Molecular imaging firm Blue Earth Diagnostics said that its Axumin PET imaging agent has been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer.

April 16, 2019

AC Immune highlights PET tracer results for Parkinson's

By AuntMinnieEurope.com staff writers

Swiss biopharmaceutical company AC Immune said a recent study concluded that its PET tracer showed potential for detecting and monitoring Parkinson's disease in humans.

April 14, 2019

Choline supply issues affect PET/CT studies in U.K.

By AuntMinnieEurope.com staff writers

Problems related to the supply of choline have led to delays and postponements for radiolabeled choline PET/CT scans in men suspected of having prostate cancer recurrence, according to a report published on 7 April in the Guardian.

April 9, 2019

United Imaging partners with ITM

By AuntMinnieEurope.com staff writers

Shanghai-based United Imaging Healthcare (UIH) has signed a worldwide strategic sales and marketing agreement with radiopharmaceutical supplier ITM Isotopen Technologien München.

April 2, 2019

Focused ultrasound releases cancer drugs on target

By Tami Freeman, PhD

Researchers from the U.K. are using computational planning models to determine the focused ultrasound parameters required to release drugs from liposomes, without the need for real-time thermometry. This approach could make ultrasound-mediated targeted drug delivery more widely accessible and simpler to administer than techniques that use MRI guidance.

March 28, 2019

NHS England cancels privatization plan for Oxford

By AuntMinnieEurope.com staff writers

Following vehement opposition from cancer patients and U.K. Members of Parliament, National Health Service (NHS) England has reversed its plan to privatize PET/CT scanning services for cancer patients at Churchill Hospital in Oxford, according to a 27 March report in the Guardian.

March 27, 2019

PET/MRI study links inflammation to atherosclerosis

By Wayne Forrest

In a novel study that tracked employees at a Spanish bank, researchers used PET/MRI to detect signs of atherosclerotic disease and inflammation in arterial regions that had not yet developed plaques. The finding could provide an early biomarker of future risk of heart attack and stroke.

March 25, 2019

Ga-68 PMSA PET/CT tops for prostate cancer recurrence

By Wayne Forrest

PET/CT with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) should be the choice over whole-body-MRI for detecting prostate cancer recurrence after radical prostatectomy, a German group advocates in a study published by the European Journal of Nuclear Medicine and Molecular Imaging.

March 24, 2019

MILabs takes preclinical order for top London facility

By AuntMinnieEurope.com staff writers

Preclinical imaging developer MILabs has announced an order for its VECTor PET/SPECT/optical imaging/CT system from Queen Mary University of London's Barts Cancer Institute.

March 19, 2019

Previous Page

Page 26 of 90

Next Page